Research
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2099 (Published 23 May 2017) Cite this as: BMJ 2017;357:j2099Data supplement
Web Extra
- Data Supplement - Appendix: Supplementary figures
- Data Supplement - Appendix: Supplementary materials
Related articles
- Research Published: 07 July 2009; BMJ 339 doi:10.1136/bmj.b2584
- Research Published: 16 August 2011; BMJ 343 doi:10.1136/bmj.d4656
- Research Published: 30 July 2012; BMJ 345 doi:10.1136/bmj.e4928
- Research Published: 20 November 2009; BMJ 339 doi:10.1136/bmj.b4229
- Research Published: 22 June 2011; BMJ 342 doi:10.1136/bmj.d3651
- Research Published: 27 October 2009; BMJ 339 doi:10.1136/bmj.b3914
- Research Published: 09 August 2016; BMJ 354 doi:10.1136/bmj.i4098
- Research Methods & Reporting Published: 22 June 2016; BMJ 353 doi:10.1136/bmj.i3140
- Research Published: 21 June 2012; BMJ 344 doi:10.1136/bmj.e4181
- ResearchPredicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2Published: 26 June 2008; BMJ 336 doi:10.1136/bmj.39609.449676.25
- Research Published: 13 May 2010; BMJ 340 doi:10.1136/bmj.c2442
- Research Published: 18 March 2009; BMJ 338 doi:10.1136/bmj.b880
- Research Published: 01 June 2016; BMJ 353 doi:10.1136/bmj.i2647
- Research Published: 22 May 2012; BMJ 344 doi:10.1136/bmj.e3427
- Research Article Published: 04 March 1989; British Medical Journal 298 doi:10.1136/bmj.298.6673.573
- Research Published: 31 May 2016; BMJ 353 doi:10.1136/bmj.i2610
- RESEARCH Published: 05 July 2007; BMJ doi:10.1136/bmj.39261.471806.55
- Research Published: 19 July 2007; BMJ 335 doi:10.1136/bmj.39261.471806.55
- Research Published: 31 January 2018; BMJ 360 doi:10.1136/bmj.k96
- Editorial Published: 31 January 2018; BMJ 360 doi:10.1136/bmj.k275
- Practice Published: 23 March 2018; BMJ 360 doi:10.1136/bmj.k835
- Research Methods & Reporting Published: 18 March 2020; BMJ 368 doi:10.1136/bmj.m441
- Research Published: 20 October 2020; BMJ 371 doi:10.1136/bmj.m3731
- Research Published: 04 November 2020; BMJ 371 doi:10.1136/bmj.m3919
- Research Published: 17 September 2021; BMJ 374 doi:10.1136/bmj.n2244
- Research Published: 21 September 2022; BMJ 378 doi:10.1136/bmj-2022-071185
- Research Published: 08 November 2022; BMJ 379 doi:10.1136/bmj-2022-070918
- Research Methods & Reporting Published: 07 February 2023; BMJ 380 doi:10.1136/bmj-2022-071018
- Research Methods & Reporting Published: 07 February 2023; BMJ 380 doi:10.1136/bmj-2022-071058
- Research Methods & Reporting Published: 03 May 2023; BMJ 381 doi:10.1136/bmj-2022-073538
- Research Published: 10 May 2023; BMJ 381 doi:10.1136/bmj-2022-073800
- Research Published: 21 June 2023; BMJ 381 doi:10.1136/bmj-2022-072976
- Analysis Published: 31 July 2023; BMJ 382 doi:10.1136/bmj-2022-074265
See more
- Sixty seconds on . . . 10 000 stepsBMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598
- Scarlett McNally: Enabling active travel can improve the UK’s healthBMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522
- Scarlett McNally: Boosting swimming for health and joyBMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393
- Variability in blood pressure could help predict heart attack and stroke risk, researchers sayBMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- Prediction of cardiovascular events in older patients with hypertension in primary care: a cohort study
- Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model
- Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy
- Predictive value of lung function measures for cardiovascular risk: a large prospective cohort study
- Predicting incident heart failure from population-based nationwide electronic health records: protocol for a model development and validation study
- Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: An actionable, explainable and biologically plausible platform
- Interpretable Machine Learning Leverages Proteomics to Improve Cardiovascular Disease Risk Prediction and Biomarker Identification
- Northern Shanghai Study II: systematic assessment and management of early organ damage and its role in preventing and reducing cardiovascular risk--protocol of a prospective study
- Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study
- Predictive value of metabolic profiling in cardiovascular risk scores: analysis of 75 000 adults in UK Biobank
- Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools
- QRISK3 underestimates the risk of cardiovascular events in patients with COPD
- PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT): a prospective longitudinal study protocol investigating the prevalence, severity and determinants of atherosclerotic cardiovascular disease in the young adult Pakistani population
- Atherosclerotic cardiovascular disease risk prediction: current state-of-the-art
- ChineseCVD: first-in-world, web-based, Chinese-specific Cardiovascular Risk Calculator incorporating long COVID, COVID-19 vaccination, SGLT2i and PCSK9i treatment effects
- Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
- Sex-Specific Association Between Genetic Risk of Psychiatric Disorders and Cardiovascular Diseases
- Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
- Towards mitigating health inequity via machine learning: a nationwide cohort study to develop and validate ethnicity-specific models for prediction of cardiovascular disease risk in COVID-19 patients
- A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk
- State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus
- Early prediction of left ventricular function improvement in patients with new-onset heart failure and presumed non-ischaemic aetiology
- Application of EULAR and European Society of Cardiology recommendations with regard to blood pressure and lipid management in antiphospholipid syndrome
- Blood protein levels predict leading incident diseases and mortality in UK Biobank
- How group structure impacts the numbers at risk for coronary artery disease: polygenic risk scores and non-genetic risk factors in the UK Biobank cohort
- Re-evaluating national screening for chronic kidney disease in the UK
- Metabolomic and genomic prediction of common diseases in 477,706 participants in three national biobanks
- Assessing violence risk in first-episode psychosis: external validation, updating and net benefit of a prediction tool (OxMIV)
- Large-language-model-based 10-year risk prediction of cardiovascular disease: insight from the UK biobank data
- Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study
- Transparent reporting of multivariable prediction models for individual prognosis or diagnosis: checklist for systematic reviews and meta-analyses (TRIPOD-SRMA)
- National Institute for Health and Care Excellence guidelines for lipid management
- Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study
- Epigenetic contributions to clinical risk prediction of cardiovascular disease
- Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)s recommendations for cardiovascular risk management?
- ADVANCE-TBI study protocol: traumatic brain injury outcomes in UK military personnel serving in Afghanistan between 2003 and 2014 - a longitudinal cohort study
- Polygenic score informed by genome-wide association studies of multiple ancestries and related traits improves risk prediction for coronary artery disease
- Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE
- Transparent reporting of multivariable prediction models developed or validated using clustered data (TRIPOD-Cluster): explanation and elaboration
- Transparent reporting of multivariable prediction models developed or validated using clustered data: TRIPOD-Cluster checklist
- Assessing eligibility for lung cancer screening: Parsimonious multi-country ensemble machine learning models for lung cancer prediction
- Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study
- Association between coeliac disease and cardiovascular disease: prospective analysis of UK Biobank data
- THE STATE OF CURRENT MANAGEMENT OF THE HEIGHTENED RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR EVENTS IN AN ESTABLISHED COHORT OF PATIENTS WITH LUPUS ERYTHEMATOSUS
- Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study
- Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
- Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population
- Artificial intelligence-enabled retinal vasculometry for prediction of circulatory mortality, myocardial infarction and stroke
- The eyes as a window to the heart: looking beyond the horizon
- National Institute for Health and Care Excellence guidelines for lipid management
- Risky business: a single-centre cross-sectional analysis of calculated cardiovascular risk in patients with primary aldosteronism and essential hypertension
- Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study
- Vascular Risk Score and Associations With Past, Current, or Future Migraine in Women: Cohort Study
- External validation of a prediction model for estimating fat mass in children and adolescents in 19 countries: individual participant data meta-analysis
- Approach to risk stratification of atherosclerotic cardiovascular disease: Use of biomarkers and imaging in a Canadian context
- Approche de la stratification du risque de maladies cardiovasculaires atherosclereuses: Utilisation des biomarqueurs et de limagerie en contexte canadien
- Predicting work disability among people with chronic conditions: a large prospective cohort study
- QCovid 4 - Predicting risk of death or hospitalisation from COVID-19 in adults testing positive for SARS-CoV-2 infection during the Omicron wave in England
- Whats new in non-alcoholic fatty liver disease?
- Clinical code usage in UK general practice: a cohort study exploring 18 conditions over 14 years
- An independent external validation of the QRISK3 cardiovascular risk prediction model applied to UK Biobank participants
- Reviewing the use and quality of machine learning in developing clinical prediction models for cardiovascular disease
- A new and automated risk prediction of coronary artery disease using clinical endpoints and medical imaging-derived patient-specific insights: protocol for the retrospective GeoCAD cohort study
- Predicting the future risk of lung cancer: development and validation of QCancer2 (10-year risk) lung model and evaluating the model performance of nine prediction models
- Development of a Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank
- Polygenic Risk Score Improves the Accuracy of a Clinical Risk Score for Coronary Artery Disease
- EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
- Artificial intelligence enabled retinal vasculometry for prediction of circulatory mortality, myocardial infarction and stroke
- Developing a model for predicting impairing physical symptoms in children 3 months after a SARS-CoV-2 PCR-test: The CLoCk Study
- Cross-sectional analysis of educational inequalities in primary prevention statin use in UK Biobank
- Development and validation of a cardiovascular diseases risk prediction model for Chinese males (CVDMCM)
- Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
- Validating risk models versus age alone for atrial fibrillation in a young Dutch population cohort: should atrial fibrillation risk prediction be expanded to younger community members?
- Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK
- Coronary artery disease in East and South Asians: differences observed on cardiac CT
- Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the QResearch(R) database: research protocol and statistical analysis plan
- Cardiovascular Risk Models in Chronic Kidney Disease: A Systematic Review and External Validation of Models
- Development, validation, and evaluation of prediction models to identify individuals at high risk of lung cancer for screening in the English primary care population using the QResearch(R) database: research protocol and statistical analysis plan
- Gaps in antihypertensive and statin treatments and benefits of optimisation: a modelling study in a 1 million ethnically diverse urban population in UK
- Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical data
- Incidence, nature and causes of avoidable significant harm in primary care in England: retrospective case note review
- Actionable absolute risk prediction of atherosclerotic cardiovascular disease: a behavior-management approach based on data from 464,547 UK Biobank participants
- Influence of physical activity, the Mediterranean diet and sociodemographic variables on the values of different cardiovascular risk scales
- Predicting patient-level new-onset atrial fibrillation from population-based nationwide electronic health records: protocol of FIND-AF for developing a precision medicine prediction model using artificial intelligence